Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Quantifying the Breadth and Duration of Immunity Induced by Meningococcal B Vaccines
Cortical Excitability: Biomarker and Endophenotype in Combat Related PTSD
Extrinsic Modulation of Protein/Ligand Recognition
Molecular Analysis of Neutrophil Activation by Chemoattractants
Endothelial Cells in Inflammation
Recently added grants:
New ACE2 activator and its prodrug as novel therapeutic reagents for inflammatory pulmonary diseases
Animal Core
Pilot Project Core
Research Project 1: The CASP4/11-GSDMD Pathway in Alcoholic Hepatitis
Non-coding RNA functions in tumor metastasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-005
Application #
6828837
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant